Insurers may selectively cover emerging cholesterol medication. But those who have taken the injection as part of a clinical trial need to inform the insurer as their risk assessment changes.
Khyati Dharamsi is a Freelance Finance Writer at moneycontrol.com. She covers a diverse range of topics including taxes, markets, LGBTQ issues, social issues, and scams, highlighting the intersection of finance and societal themes. Khyati's work has been featured in prominent publications, showcasing her commitment to insightful financial journalism.